Cipla (CIPLA) Q4 08/09 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 08/09 earnings summary
15 Oct, 2026Executive summary
FY09 turnover exceeded Rs.5,000 crore, up 22%; exports grew 30% and domestic sales 15%, while PAT rose 11% to Rs.776.81 crore.
Profit growth was moderated by foreign-exchange hedging effects; the year included a net FX charge of Rs.228.37 crore versus a Rs.67.08 crore credit in FY08.
Financial highlights
Sales and other income rose to Rs.5,326.77 crore from Rs.4,338.21 crore; net sales were Rs.4,960.60 crore versus Rs.3,997.90 crore.
PBT increased 8% to Rs.901.31 crore; PAT increased 11% to Rs.776.81 crore, from Rs.701.43 crore.
EPS was Rs.9.99 versus Rs.9.02; proposed dividend was Rs.2 per share, totaling Rs.155.46 crore.
Technical know-how fees reached Rs.217.75 crore, up 42%; export incentives were Rs.55.94 crore.
Outlook and guidance
Organic growth opportunities, stronger working capital and possible debt retirement were identified as intended uses for a proposed securities issue of up to Rs.1,500 crore.
Indore SEZ validation batches were planned for FY10, with commercial production expected in the following year.
International expansion strategy relies on product registrations, strategic partnerships and technical know-how; exports span more than 180 countries.
Latest events from Cipla
- FY18 margins expanded and PAT rose 40%, despite US pricing and launch headwinds.CIPLA
Q4 17/18 - Revenue grew 12%, while record margins and cash generation strengthened FY21 performance.CIPLA
Q4 20/21 - Record FY22 revenue, with growth led by India, North America and SAGA.CIPLA
Q4 21/22 - Record revenue and EBITDA, led by India and North America, amid regulatory and pricing risks.CIPLA
Q4 22/23 - Revenue rose 8% as core markets lifted EBITDA margin to 19.4%.CIPLA
Q4 18/19 - Core-market growth lifted FY17, but impairments and market pressures constrained reported results.CIPLA
Q4 16/17 - Revenue topped ₹10,000 crore, but profit declined as investment and mix pressured margins.CIPLA
Q4 13/14 - Revenue rose 11.5%, but profit fell 15% as mix and investment pressured margins.CIPLA
Q4 14/15 - Record PAT and stronger cash flow offset COVID-19, pricing and regulatory headwinds.CIPLA
Q4 19/20 - FY16 growth accelerated, while acquisition debt and pricing litigation raised risks.CIPLA
Q4 15/16